Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient
Uber, L.; Cofer, J.; Baliga, P.; Rajagopalan, P.R.
Transplantation Proceedings 27(5 Suppl 1: 42-43
1995
ISSN/ISBN: 0041-1345 PMID: 7482818 Document Number: 446300
Document emailed within 1 workday
Related Documents
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897Moreno, J.; Montero, J.L.; Gavilán, F.; Costán, G.; Herrero, C.; Cárdenas, M.; Sánchez-Guijo, P.; Torre-Cisneros, J. 1999: Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(8): 382-385
Dreikorn, K.; Doerr, H.W.; Geursen, R.G. 1985: Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG Scandinavian Journal of Urology and Nephrology. Supplementum 92: 15-21
Harland, R.C.; Vernon, W.B.; Bunzendahl, H.; Thompson, J.K.; Lawrence, C.; Bollinger, R.R. 1994: Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients Transplantation Proceedings 26(2): 432-433
Shen, G.K.; Alfrey, E.J.; Knoppel, C.L.; Dafoe, D.C.; Scandling, J.D. 1997: Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation Transplantation 64(6): 931-933
Waid, T.H.; McKeown, J.W. 1995: Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation Transplantation Proceedings 27(5 Suppl 1: 46
Snydman, D.R.; Werner, B.G.; Dougherty, N.N.; Griffith, J.; Rohrer, R.H.; Freeman, R.; Jenkins, R.; Lewis, W.D.; O'Rourke, E. 1994: A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group Transplantation Proceedings 26(5 Suppl 1: 23-27
Kawalec, P.ł; Holko, P.ła.; Szkultecka-Debek, M.; Paszulewicz, A.; Boratyńska, M.; Głyda, M.; Ignacak, E.; Maks, J.; Russel-Szymczyk, M.; Kaweczyńska-Lasoń, A. 2013: The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(204): 332-338
Horng, I.H.; Chen, M.S.; Lee, P.H.; Chen, Y.C.; Lee, C.S.; Hou, P.K. 1989: Cytomegalovirus retinitis treated with ganciclovir in a renal transplant recipient Journal of the Formosan Medical Association 88(11-12): 1152-1155
Cheng, J-Wei.; Chen, Y-Chang.; Tian, Y-Chung.; Fang, J-Tseng.; Yang, C-Wei. 2007: Coinfection of cytomegalovirus and miliary tuberculosis in a post-renal transplant recipient Journal of Nephrology 20(1): 114-118
Lawson-Ananissoh, L.M.; Anzouan-Kacou, Y.H.K.; Tsevi, Y.M.; Ackoundou-N'Guessan, K.C.; Attia, K.A. 2019: Effectiveness of the Treatment of Chronic Hepatitis C Virus Infection Genotype 2 by the Combination Sofosbuvir/Ledipasvir in a Black African Kidney Transplant West African Journal of Medicine 36(3): 280-282
Pucci, A.; Grasso, M.; Arbustini, E. 1989: Myocardial involvement due to a disseminated human cytomegalovirus infection in a heart transplant recipient. A case report Giornale Italiano di Cardiologia 19(3): 230-233
Gilliam, G. 1992: A kidney transplant recipient says "thanks for the memories" Nephrology News and Issues 6(3): 18-19
Valderrábano, F.; Anaya, F.; Robles, N.R.; Jofré, R. 1988: Sequential therapy with anti-thymocyte globulin and cyclosporine a in oligoanuric high-risk cadaveric kidney graft recipients Transplantation Proceedings 20(5 Suppl 6: 75-78
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Hauser, S.P. 1995: Case management of the kidney transplant recipient Anna Journal 22(4): 369-374
Kapoor, N.; Copelan, E.A.; Tutschka, P.J. 1989: Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent Transplantation Proceedings 21(1 Part 3): 3095-3096
Matsumiya, G.; Nakano, S.; Shirakura, R.; Nakata, S.; Fukushima, N.; Matsuda, H. 1994: Aortic valve replacement in a kidney transplant recipient Nihon Kyobu Geka Gakkai 42(6): 956-960
Tan, S.Y.; Lim, C.S.; Teo, S.M.; Lee, S.H.; Razack, A.; Loh, C.S. 2003: Peritoneal implantation of ureter in a cadaveric kidney transplant recipient Medical Journal of Malaysia 58(5): 769-770
Viertel, A.; Ditting, T.; Pistorius, K.; Geiger, H.; Scheuermann, E.H.; Just-Nübling, G. 1999: An unusual case of Aspergillus endocarditis in a kidney transplant recipient Transplantation 68(11): 1812-1813